Published July 29, 2025 | Version v1

A Review on Non-Benzodiazepines as Oral Sedative Agents : A Safer Alternative for Clinical and Paediatric Use

Contributors

Producer:

Description

Abstract
Non-benzodiazepines, often referred to as “Z-drugs,” have gained prominence as safer and more targeted alternatives to traditional benzodiazepines in the management of anxiety and sleep disorders. This review explores their pharmacological profile, mechanism of action, and clinical relevance. Structurally distinct from benzodiazepines, non-benzodiazepines act as positive allosteric modulators of the GABA-A receptor, with selective binding to the alpha-1 subunit. This receptor specificity produces effective sedative action while minimizing common benzodiazepine-associated side effects such as psychomotor impairment, memory disruption, and alteration of sleep architecture. Agents such as zolpidem, zaleplon, zopiclone, and eszopiclone vary in their pharmacokinetics and duration of action, making them suitable for individualized
treatment strategies. Based on duration, non-benzodiazepines can be classified as short-, intermediate-, or long-acting. This review highlights the therapeutic potential and safety profile of non-benzodiazepines, emphasizing their role as first-line agents in the treatment of insomnia and related conditions. Their clinical utility, combined with a lower risk of dependence and adverse effects, supports their growing use in modern pharmacotherapy.


Keywords - Non-Benzodiazepine, Zolpidam, Zaleplon, Zopiclone, Eszopiclone

Files

Dr Udita-P19-23.pdf

Files (3.7 MB)

Name Size
md5:8a2f6fdffa0f73d80787bab6a66ac800
3.7 MB Preview Download

Additional details

Dates

Available
2025-07-29